Viral Hemorrhagic Fever
What's New
Last Posted: Mar 15, 2023
- Association of eNOS gene 4a/4b VNTR and T786C polymorphism with Crimean-Congo hemorrhagic fever.
Say Coskun Umut Safiye, et al. Nucleosides, nucleotides & nucleic acids 2022 0 1-9 - Effects of Paraoxonase-1 variants on course of severity and mortality of Crimean-Congo hemorrhagic fever.
Karakus Nevin, et al. Gene 2019 3 188-192 - Viral hemorrhagic fever
From NCATS Genetic and Rare Diseases Information Center - Toll-like receptor 8 and 9 polymorphisms in Crimean-Congo hemorrhagic fever.
Engin Aynur, et al. Microbes and infection / Institut Pasteur 2010 11 (12-13) 1071-8
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: